Dawkins F W, Kim K S, Squires R S, Chisholm R, Kark J A, Perlin E, Castro O
Department of Medicine, Howard University College of Medicine, Washington, DC 20060, USA.
Am J Hematol. 1997 Aug;55(4):188-92. doi: 10.1002/(sici)1096-8652(199707)55:4<188::aid-ajh4>3.0.co;2-o.
The incidence of cancer in patients with sickle cell disease (SCD) is not known. The 10-year follow-up data on 696 patients with SCD was analyzed at our institution in order to determine the cancer incidence and cancer mortality rates. The age range was 18 to 79 years, with a mean age of 28.8 years. There were 377 females and 319 males. The median follow-up was 3 years. Five patients developed cancer during this period. The cancer incidence rate was 5/2,864 or 1.74 per 1,000 patient years. The 95% CI was 0.64 to 4.32 per 1,000 patient years. There were 68 deaths with 3 being due to cancer. The cancer mortality rate was 3/2,873 or 1.04 cases per 1,000 patient years. Our data represent the first published paper that the authors are aware of, where the cancer incidence and mortality rates have been calculated for any group of patients with SCD.
镰状细胞病(SCD)患者的癌症发病率尚不清楚。我们机构分析了696例SCD患者的10年随访数据,以确定癌症发病率和癌症死亡率。年龄范围为18至79岁,平均年龄为28.8岁。其中有377名女性和319名男性。中位随访时间为3年。在此期间有5名患者患癌。癌症发病率为5/2864,即每1000患者年1.74例。95%置信区间为每1000患者年0.64至4.32例。共有68例死亡,其中3例死于癌症。癌症死亡率为3/2873,即每1000患者年1.04例。据作者所知,我们的数据是首篇发表的计算了任何一组SCD患者癌症发病率和死亡率的论文。